Interaction between mild hypercholesterolemia, HDL-cholesterol levels, and angiotensin II in intimal hyperplasia in mice

Journal of Lipid Research

Volumn 47, Issue 3, 2006, Pages 476-483

  Da Cunha, Valdeci ^a   Martin McNulty, Baby ^a   Vincelette, Jon ^a   Zhang, Lening ^b   Rutledge, John C ^b   Wilson, Dennis W ^c   Vergona, Ronald ^a   Sullivan, Mark E ^a   Wang, Yi Xin ^a  

^a BAYER AG   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

High density lipoprotein; Smooth muscle cells; Vascular remodeling

Indexed keywords

ANGIOTENSIN II; CHOLIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY DIAMETER; ARTERY INTIMA PROLIFERATION; ARTICLE; CAROTID ARTERY LIGATION; CELL PROLIFERATION; CONTROLLED STUDY; DIETARY INTAKE; DISEASE SEVERITY; FEEDING; HYPERCHOLESTEROLEMIA; LIPOPROTEIN BLOOD LEVEL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER;

ANGIOTENSIN II; ANIMALS; CAROTID ARTERIES; CHOLESTEROL, HDL; DIET; HYPERCHOLESTEROLEMIA; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; LIPID METABOLISM; MICE; MICE, INBRED C57BL;

EID: 33644785829     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M500341-JLR200     Document Type: Article

References (44)

1. Waller, B. F. 1989. Pathology of transluminal balloon angioplasty used in the treatment of coronary heart disease. Cardiol. Clin. 7: 749-770.
2. Farb, A., F. D. Kolodgie, J. Y. Hwang, A. P. Burke, K. Tefera, D. K. Weber, T. N. Wight, and R. Virmani. 2004. Extracellular matrix changes in stented human coronary arteries. Circulation. 110: 940-947.
3. Motwani, J. G., and E. J. Topol. 1998. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation. 97: 916-931.
4. Sims, F. H. 1989. A comparison of structural features of the walls of coronary arteries from 10 different species. Pathology. 21: 115-124.
5. Theilmeier, G., R. Quarck, P. Verhamme, M. L. Bochaton-Piallat, M. Lox, H. Bernar, S. Janssens, M. Kockx, G. Gabbiani, D. Collen, et al. 2002. Hypercholesterolemia impairs vascular remodelling after porcine coronary angioplasty. Cardiovasc. Res. 55: 385-395.
6. Kahn, M. B., K. Boesze-Battaglia, D. W. Stepp, A. Petrov, Y. Huang, R. P. Mason, and T. N. Tulenko. 2005. Influence of serum cholesterol on atherogenesis and intimal hyperplasia after angioplasty: inhibition by amlodipine. Am. J. Physiol. Heart Circ. Physiol. 288: H591-H600.
7. Bacakova, L., J. Herget, and J. Wilhelm. 1999. Influence of macrophages and macrophage-modified collagen I on the adhesion and proliferation of vascular smooth muscle cells in culture. Physiol. Res. 48: 341-351.
8. Wentzel, J. J., F. J. Gijsen, N. Stergiopulos, P. W. Serruys, C. J. Slager, and R. Krams. 2003. Shear stress, vascular remodeling and neointimal formation. J. Biomech. 36: 681-688.
9. Yoshida, O., H. Hirayama, M. Nanasato, T. Watanabe, and T. Murohara. 2005. The angiotensin II receptor blocker candesartan cilexetil reduces neointima proliferation after coronary stent implantation: a prospective randomized study under intravascular ultrasound guidance. Am. Heart J. 149: e2.
10. Wang, M., G. Takagi, K. Asai, R. G. Resuello, F. F. Natividad, D. E. Vatner, S. F. Vatner, and E. G. Lakatta. 2003. Aging increases aortic MMP-2 activity and angiotensin II in nonhuman primates. Hypertension. 41: 1308-1316.
11. Wagenaar, L. J., A. J. van Boven, A. C. van der Wal, G. Amoroso, R. A. Tio, C. M. van der Loos, A. E. Becker, and W. H. van Gilst. 2003. Differential localisation of the renin-angiotensin system in de-novo lesions and in-stent restenotic lesions in in-vivo human coronary arteries. Cardiovasc. Res. 59: 980-987.
12. Bochkov, V. N., V. A. Tkachuk, A. W. Hahn, J. Bernhardt, F. R. Buhler, and T. J. Resink. 1993. Concerted effects of lipoproteins and angiotensin II on signal transduction processes in vascular smooth muscle cells. Arterioscler. Thromb. 13: 1261-1269.
13. Nickenig, G., A. Sachinidis, F. Michaelsen, M. Bohm, S. Seewald, and H. Vetter. 1997. Upregulation of vascular angiotensin II receptor gene expression by low-density lipoprotein in vascular smooth muscle cells. Circulation. 95: 473-478.
14. Kumar, A., and V. Lindner. 1997. Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow. Arterioscler. Thromb. Vasc. Biol. 17: 2238-2244.
15. da Cunha, V., D. M. Tham, B. Martin-McNulty, G. Deng, J. J. Ho, D. W. Wilson, J. C. Rutledge, R. Vergona, M. E. Sullivan, and Y. X. Wang. 2005. Enalapril attenuates angiotensin II-induced atherosclerosis and vascular inflammation. Atherosclerosis. 178: 9-17.
16. Singh, R., S. Pan, C. S. Mueske, T. A. Witt, L. S. Kleppe, T. E. Peterson, N. M. Caplice, and R. D. Simari. 2003. Tissue factor pathway inhibitor deficiency enhances neointimal proliferation and formation in a murine model of vascular remodelling. Thromb. Haemost. 89: 747-751.
17. van Oostrom, O., E. Velema, A. H. Schoneveld, J. P. de Vries, P. de Bruin, C. A. Seldenrijk, D. P. de Kleijn, E. Busser, F. L. Moll, J. H. Verheijen, et al. 2005. Age-related changes in plaque composition. A study in patients suffering from carotid artery stenosis. Cardiovasc. Pathol. 14: 126-134.
18. Paigen, B., A. Morrow, C. Brandon, D. Mitchell, and P. Holmes. 1985. Variation in susceptibility to atherosclerosis among inbred strains of mice. Atherosclerosis. 57: 65-73.
19. Nageh, M. F., E. T. Sandberg, K. R. Marotti, A. H. Lin, E. P. Melchior, D. C. Bullard, and A. L. Beaudet. 1997. Deficiency of inflammatory cell adhesion molecules protects against atherosclerosis in mice. Arterioscler. Thromb. Vasc. Biol. 17: 1517-1520.
20. Stone, P. H., A. U. Coskun, S. Kinlay, M. E. Clark, M. Sonka, A. Wahle, O. J. Ilegbusi, Y. Yeghiazarians, J. J. Popma, J. Orav, et al. 2003. Effect of endothelial shear stress on the progression of coronary artery disease, vascular remodeling, and in-stent restenosis in humans: in vivo 6-month follow-up study. Circulation. 108: 438-444.
21. Bretschneider, E., M. Braun, A. Fischer, M. Wittpoth, E. Glusa, and K. Schror. 2000. Factor Xa acts as a PDGF-independent mitogen in human vascular smooth muscle cells. Thromb. Haemost. 84: 499-505.
22. Feinberg, M. W., K. Shimizu, M. Lebedeva, R. Haspel, K. Takayama, Z. Chen, J. P. Frederick, X. F. Wang, D. I. Simon, P. Libby, et al. 2004. Essential role for Smad3 in regulating MCP-1 expression and vascular inflammation. Circ. Res. 94: 601-608.
23. Ivan, E., J. J. Khatri, C. Johnson, R. Magid, D. Godin, S. Nandi, S. Lessner, and Z. S. Galis. 2002. Expansive arterial remodeling is associated with increased neointimal macrophage foam cell content: the murine model of macrophage-rich carotid artery lesions. Circulation. 105: 2686-2691.
24. Paigen, B., D. Mitchell, K. Reue, A. Morrow, A. J. Lusis, and R. C. LeBoeuf. 1987. Ath-1, a gene determining atherosclerosis susceptibility and high density lipoprotein levels in mice. Proc. Natl. Acad. Sci. USA. 84: 3763-3767.
25. Huber, S. A., P. Sakkinen, C. David, M. K. Newell, and R. P. Tracy. 2001. T helper-cell phenotype regulates atherosclerosis in mice under conditions of mild hypercholesterolemia. Circulation. 103: 2610-2616.
26. Stokes, K. Y., E. C. Clanton, J. L. Gehrig, and D. N. Granger. 2003. Role of interleukin 12 in hypercholesterolemia-induced inflammation. Am. J. Physiol. Heart Circ. Physiol. 285: H2623-H2629.
27. Plump, A. S., J. D. Smith, T. Hayek, K. Aalto-Setala, A. Walsh, J. G. Verstuyft, E. M. Rubin, and J. L. Breslow. 1992. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 71: 343-353.
28. Jolley, C. D., J. M. Dietschy, and S. D. Turley. 1999. Genetic differences in cholesterol absorption in 129/Sv and C57BL/6 mice: effect on cholesterol responsiveness. Am. J. Physiol. 276: G1117-G1124.
29. Nishina, P. M., J. Verstuyft, and B. Paigen. 1990. Synthetic low and high fat diets for the study of atherosclerosis in the mouse. J. Lipid Res. 31: 859-869.
30. Machleder, D., B. Ivandic, C. Welch, L. Castellani, K. Reue, and A. J. Lusis. 1997. Complex genetic control of HDL levels in mice in response to an atherogenic diet. Coordinate regulation of HDL levels and bile acid metabolism. J. Clin. Invest. 99: 1406-1419.
31. Liao, F., A. Andalibi, F. C. deBeer, A. M. Fogelman, and A. J. Lusis. 1993. Genetic control of inflammatory gene induction and NF-kappa B-like transcription factor activation in response to an atherogenic diet in mice. J. Clin. Invest. 91: 2572-2579.
32. Jawien, J., P. Nastalek, and R. Korbut. 2004. Mouse models of experimental atherosclerosis. J. Physiol. Pharmacol. 55: 503-517.
33. Stein, O., Y. Dabach, G. Hollander, M. Ben-Naim, G. Halperin, and Y. Stein. 2001. Effect of atherogenic diet on reverse cholesterol transport in vivo in atherosclerosis susceptible (C57BL/6) and resistant (C3H) mice. Atherosclerosis. 156: 307-313.
34. Yan, D., M. Navab, C. Bruce, A. M. Fogelman, and X. C. Jiang. 2004. PLTP deficiency improves the anti-inflammatory properties of HDL and reduces the ability of LDL to induce monocyte chemotactic activity. J. Lipid Res. 45: 1852-1858.
35. Wang, Z., P. J. Rao, S. D. Shillcutt, and W. H. Newman. 2005. Angiotensin II induces proliferation of human cerebral artery smooth muscle cells through a basic fibroblast growth factor (bFGF) dependent mechanism. Neurosci. Lett. 373: 38-41.
36. Zhao, Y., J. Liu, L. Li, L. Liu, and L. Wu. 2005. Role of Ras/PKCzeta/MEK/ERK1/2 signaling pathway in angiotensin II-induced vascular smooth muscle cell proliferation. Regul. Pept. 128: 43-50.
37. Kim, D., T. Aizawa, H. Wei, X. Pi, S. D. Rybalkin, B. C. Berk, and C. Yan. 2005. Angiotensin II increases phosphodiesterase 5A expression in vascular smooth muscle cells: a mechanism by which angiotensin II antagonizes cGMP signaling. J. Mol. Cell. Cardiol. 38: 175-184.
38. Denger, S., L. Jahn, P. Wende, L. Watson, S. H. Gerber, W. Kubler, and J. Kreuzer. 1999. Expression of monocyte chemoattractant protein-1 cDNA in vascular smooth muscle cells: induction of the synthetic phenotype. A possible clue to SMC differentiation in the process of atherogenesis. Atherosclerosis. 144: 15-23.
39. Zalewski, A., Y. Shi, and A. G. Johnson. 2002. Diverse origin of intimal cells: smooth muscle cells, myofibroblasts, fibroblasts, and beyond? Circ. Res. 91: 652-655.
40. Shi, Y., R. Niculescu, D. Wang, S. Patel, K. L. Davenpeck, and A. Zalewski. 2001. Increased NAD(P)H oxidase and reactive oxygen species in coronary arteries after balloon injury. Arterioscler. Thromb. Vasc. Biol. 21: 739-745.
41. Ishikawa, M., K. Y. Stokes, J. H. Zhang, A. Nanda, and D. N. Granger. 2004. Cerebral microvascular responses to hypercholesterolemia: roles of NADPH oxidase and P-selectin. Circ. Res. 94: 239-244.
42. Wang, H. D., S. Xu, D. G. Johns, Y. Du, M. T. Quinn, A. J. Cayatte, and R. A. Cohen. 2001. Role of NADPH oxidase in the vascular hypertrophic and oxidative stress response to angiotensin II in mice. Circ. Res. 88: 947-953.
43. Wyttenbach, R., A. Gallino, M. Alerci, F. Mahler, L. Cozzi, M. Di Valentino, J. J. Badimon, V. Fuster, and R. Corti. 2004. Effects of percutaneous transluminal angioplasty and endovascular brachytherapy on vascular remodeling of human femoropopliteal artery by noninvasive magnetic resonance imaging. Circulation. 110: 1156-1161.
44. Mason, D. P., R. D. Kenagy, D. Hasenstab, D. F. Bowen-Pope, R. A. Seifert, S. Coats, S. M. Hawkins, and A. W. Clowes. 1999. Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery. Circ. Res. 85: 1179-1185.